TLR4 and neoplasm: further found that in TLR2 and TLR4 agonist-stimulated monocytes/macrophages and tumor-infiltrating immune cells, tumor cells could secrete lactate to activate the IL-23/IL-17 pathway and promote tumorigenesis and growth by promoting angiogenesis and triggering a local inflammatory response (66).